Abstract
Xiaozhen Wang, Wenya Su, Hongyue Tian, Luqi Huang, Lanping Guo, Wenyuan Gao
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Host-microbiota interactions in inflammatory bowel disease
10.1038/s41575-019-0248-1 · 2020
Global research trends of immunotherapy and biotherapy for inflammatory bowel disease: A bibliometric analysis from 2002 to 2021
10.1186/s12938-022-01011-9 · 2022
An antioxidant metal-organic framework with functional coatings for oral anti-TNF-α antibody delivery in inflammatory bowel disease treatment
10.1016/j.jconrel.2025.114411 · 2026
Natural products-integrated drug delivery systems as innovative therapeutic strategies for inflammatory bowel disease management
10.26599/nr.2025.94908007 · 2025
Design of therapeutic biomaterials to control inflammation
10.1038/s41578-022-00426-z · 2022
Oral administration of nanozyme-armed probiotic Escherichia coli Nissle 1917 with ROS scavenging for inflammatory bowel disease therapy
10.1016/j.cej.2025.164949 · 2025
Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: A systematic review and meta-analysis
10.2139/ssrn.3746277 · 2021
From gut inflammation to psychiatric comorbidity: Mechanisms and therapies for anxiety and depression in inflammatory bowel disease
10.1186/s12974-025-03476-6 · 2025
Engineered probiotics enable targeted gut delivery of dual gasotransmitters for inflammatory bowel disease therapy
10.1002/anie.202502588 · 2025
An olsalazine nanoneedle-embedded inulin hydrogel reshapes intestinal homeostasis in inflammatory bowel disease
10.1016/j.bioactmat.2023.10.028 · 2024
Advances in prebiotic carbohydrate-based targeted delivery: Overcoming gastrointestinal challenges for bioactive ingredients
10.1016/j.foodchem.2024.142210 · 2025
Inflammatory bowel disease: The emergence of new trends in lifestyle and nanomedicine as the modern tool for pharmacotherapy
10.3390/nano10122460 · 2020
Fungal β-glucan-based nanotherapeutics: From fabrication to application
10.3390/jof9040475 · 2023
Yeast β-glucan attenuates dextran sulfate sodium-induced colitis: Involvement of gut microbiota and short-chain fatty acids
10.1016/j.ijbiomac.2024.135846 · 2024
Yeast beta-glucan supplementation with multivitamins attenuates cognitive impairments in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: A randomized, double-blind, placebo-controlled trial
10.3390/nu15214504 · 2023
Yeast β-glucan alleviates high-fat diet-induced Alzheimer's disease-like pathologies in rats via the gut-brain axis
10.1016/j.ijbiomac.2024.134939 · 2024
Gelation mechanism of alkali induced heat-set konjac glucomannan gel
10.1016/j.tifs.2021.07.025 · 2021
Influence of cyclodextrins on the gelation behavior of κ-carrageenan/konjac glucomannan composite gel
10.1016/j.foodhyd.2021.106927 · 2021
Fabrication and characterization of konjac glucomannan/oat β-glucan composite hydrogel: Microstructure, physicochemical properties and gelation mechanism studies
10.3390/molecules27238494 · 2022
Use of fluorescein isothiocyanate-dextran to measure proton pumping in lysosomes and related organelles
10.1016/0076-6879(89)74015-5 · 1989
Glutamate acts on acid-sensing ion channels to worsen ischaemic brain injury
10.1038/s41586-024-07684-7 · 2024
Yeast-inspired orally-administered nanocomposite scavenges oxidative stress and restores gut immune homeostasis for inflammatory bowel disease treatment
10.1021/acsnano.4c18099 · 2025
Metal-organic framework composite Mn/Fe–MOF@Pd with peroxidase-like activities for sensitive colorimetric detection of hydroquinone
10.1016/j.aca.2023.341797 · 2023
Polyphenolic nanoparticle-modified probiotics for microenvironment remodeling and targeted therapy of inflammatory bowel disease
10.1021/acsnano.4c00830 · 2024
Biosilicification-mimicking chiral nanostructures for targeted treatment of inflammatory bowel disease
10.1038/s41467-025-57890-8 · 2025
Endocytosis: The nanoparticle and submicron nanocompounds gateway into the cell
10.3390/pharmaceutics12040371 · 2020
Nanozyme-functionalized microalgal biohybrid microrobots in inflammatory bowel disease treatment
10.1016/j.biomaterials.2025.123231 · 2025
Dual-ROS sensitive moieties conjugate inhibits curcumin oxidative degradation for colitis precise therapy
10.1002/adhm.202303016 · 2024
Role of goblet cells in intestinal barrier and mucosal immunity
10.2147/jir.s318327 · 2021
Tight junction proteins in gastrointestinal and liver disease
10.1136/gutjnl-2018-316906 · 2019
Current understanding of the interplay between extracellular matrix remodelling and gut permeability in health and disease
10.1038/s41420-024-02015-1 · 2024
The tight junction protein ZO-1 is dispensable for barrier function but critical for effective mucosal repair
10.1053/j.gastro.2021.08.047 · 2021
Macrophage M1/M2 polarization
10.1016/j.ejphar.2020.173090 · 2020
Hydrogel-based artificial mucosa restores local immune and microbial homeostasis for treating ulcerative colitis
10.1002/adfm.202212566 · 2023
Current status of M1 and M2 macrophages pathway as drug targets for inflammatory bowel disease
10.1007/s00005-020-00576-4 · 2020
The bidirectional risk of inflammatory bowel disease and anxiety or depression: A systematic review and meta-analysis
10.1016/j.genhosppsych.2023.05.002 · 2023
10.1007/978-1-0716-3662-6_8
10.1007/978-1-0716-3662-6_8
Honeysuckle-derived nanovesicles regulate gut microbiota for the treatment of inflammatory bowel disease
10.1002/advs.202505208 · 2025
Gut microbiota and IBD: Causation or correlation
10.1038/nrgastro.2017.88 · 2017
High prevalence of mucosa-associated extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae among Iranain patients with inflammatory bowel disease (IBD)
10.1186/s12941-023-00630-x · 2023
Lotus seed starch-chlorogenic acid complexes alleviated chronic colitis and linked cognitive dysfunction via gut microbiota regulation: Gut-brain-axis interaction
10.1016/j.carbpol.2025.124158 · doi-reference
Crataegus pinnatifida polysaccharide alleviates DSS-induced colitis in mice by regulating the intestinal microbiota and enhancing arginine biosynthesis
10.1016/j.phymed.2025.156794 · doi-reference
Oral troxerutin alleviates depression symptoms in mice by modulating gut microbiota and microbial metabolism
10.1002/mnfr.202470007 · doi-reference
Gut microbiota-derived short-chain fatty acids and depression: Deep insight into biological mechanisms and potential applications
10.1136/gpsych-2023-101374 · doi-reference
Gut microbiota causes depressive phenotype by modulating glycerophospholipid and sphingolipid metabolism via the gut-brain axis
10.1016/j.psychres.2025.116392 · doi-reference
Inflammation-targeted delivery of probiotics for alleviation of colitis and associated cognitive disorders through improved vitality and colonization
10.1016/j.biomaterials.2025.123163 · doi-reference
Exploring GPR109A receptor interaction with hippuric acid using MD simulations and CD spectroscopy
10.3390/ijms232314778 · doi-reference
Crocetin prolongs recovery period of dss-induced colitis via altering intestinal microbiome and increasing intestinal permeability
10.3390/ijms23073832 · doi-reference
Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia
10.1242/jcs.113.17.3073 · doi-reference
Complex and regional-specific changes in the morphological complexity of GFAP+ astrocytes in middle-aged mice
10.1016/j.neurobiolaging.2020.12.018 · doi-reference
Bile acid-induced metabolic changes in the colon promote Enterobacteriaceae expansion and associate with dysbiosis in Crohn's disease
10.1126/scisignal.adl1786 · doi-reference
Loggerhead sea turtles as sentinels in the western Mediterranean: Antibiotic resistance and environment-related modifications of gram-negative bacteria
10.1016/j.marpolbul.2019.110575 · doi-reference
Gut microbiota-derived propionate regulates the expression of Reg3 mucosal lectins and ameliorates experimental colitis in mice
10.1093/ecco-jcc/jjaa065 · doi-reference
Chronological dynamics of the gut microbiome in response to the pasture grazing system in geese
10.1128/spectrum.04188-23 · doi-reference
Modulatory role of hesperetin-copper (II) on gut microbiota in type 2 diabetes mellitus mice
10.3390/foods14132390 · doi-reference
The specificity of ten non-digestible carbohydrates to enhance butyrate-producing bacteria and butyrate production in vitro fermentation
10.1016/j.fshw.2023.03.038 · doi-reference
Effects of dietary supplementation with protected sodium butyrate on gut microbiota in growing-finishing pigs
10.3390/ani11072137 · doi-reference
Maternal and/or post-weaning supplementation with Bacillus altitudinis spores modulates the microbial composition of colostrum, digesta and faeces in pigs
10.1038/s41598-023-33175-2 · doi-reference
Protective effect of fermented okara on the regulation of inflammation, the gut microbiota, and SCFAs production in rats with TNBS-induced colitis
10.1016/j.foodres.2022.111390 · doi-reference
Short-chain fatty acids augment rat duodenal mucosal barrier function
10.1113/ep086110 · doi-reference
Effect of cinnamon essential oil on gut microbiota in the mouse model of dextran sodium sulfate-induced colitis
10.1111/1348-0421.12749 · doi-reference
Insoluble fiber in barley leaf attenuates hyperuricemic nephropathy by modulating gut microbiota and short-chain fatty acids
10.3390/foods11213482 · doi-reference
The effect of a novel anticonvulsant chemical Q808 on gut microbiota and hippocampus neurotransmitters in pentylenetetrazole-induced seizures in rats
10.1186/s12868-022-00690-3 · doi-reference
Ban-Lan-Gen granule alleviates dextran sulfate sodium-induced chronic relapsing colitis in mice via regulating gut microbiota and restoring gut SCFA derived-GLP-1 production
10.2147/jir.s352863 · doi-reference
Tibetan highland barley fiber improves obesity and regulates gut microbiota in high-fat diet-fed mice
10.1016/j.fbio.2023.102620 · doi-reference
α-lactalbumin peptide Asp-Gln-Trp alleviates hepatic insulin resistance and modulates gut microbiota dysbiosis in high-fat diet-induced NAFLD mice
10.1039/d2fo01343f · doi-reference
LC-MS/MS metabolomic profiling of the protective butylphthalide effect in cerebral ischemia/reperfusion mice
10.1016/j.jstrokecerebrovasdis.2023.107347 · doi-reference
Aeromonas species: An opportunistic enteropathogen in patients with inflammatory bowel diseases
10.1097/mib.0000000000000247 · doi-reference
Therapeutic effect of Faecalibacterium longum CM04-06 on DSS-induced ulcerative colitis in mice
10.1093/jambio/lxaf119 · doi-reference
The intestinal dysbiosis found in IBD-patients are linked to colonization with extra-intestinal pathogenic Escherichia coli
10.1016/s0016-5085(17)32240-0 · doi-reference
Effect of commercial prescription diets containing prebiotics on clinical signs and fecal miocrobiome in dogs with intestinal disease
10.24425/pjvs.2024.152950 · doi-reference
Alterations in serum immune parameters, cytokines, intestinal permeability, fecal microbiota, and short-chain fatty acids in healthy and diarrheic suckling calves
10.3390/agriculture15212289 · doi-reference